Skip to main content
Suzhou Zelgen Biopharmaceuticals Co.,Ltd. (SHA:688266)
China flag China · Delayed Price · Currency is CNY
91.39
-1.81 (-1.94%)
May 14, 2025, 2:45 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '18
Pharmaceutical
383.56M
Log In
Log In
Log In
Log In
Pharmaceutical Growth
27.14%
Log In
Log In
Log In
Log In
Pharmaceutical Intermediates and Raw Materials
2.81M
Log In
Log In
Log In
Log In
Pharmaceutical Intermediates and Raw Materials Growth
342.17%
Log In
Log In
Log In
Log In
Asset Licensing
76.45K
Log In
Log In
Log In
Log In
Asset Licensing Growth
-
Log In
Log In
Log In
Log In
Technical Service
-
Log In
Log In
Log In
Log In
R & D and Clinical Trials Examination Drugs Service
-
Log In
Log In
Log In
Log In
R & D and Clinical Trials Examination Drugs Service Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '18
China
386.44M
Log In
Log In
Log In
Log In
China Growth
27.83%
Log In
Log In
Log In
Log In
Overseas
-
Log In
Log In
Log In
Log In